Thailand has been officially verified by the WHO as having eliminated rubella as a public health problem, marking a significant milestone in disease control and paving the way for intensified efforts against measles.
Thailand’s campaign against rubella has cleared one of the toughest international tests in disease control, with the World Health Organization verifying on 5 September that the country has eliminated the infection as a public-health problem. The decision makes Thailand the seventh member of WHO’s South-East Asia region to reach that point and gives Bangkok a platform to turn more of its attention to measles, which ministers say is the next target.
According to WHO’s South-East Asia office, the ruling followed a two-stage review rather than a single declaration. The regional verification commission met on 22 and 23 June 2026 to examine Thailand’s evidence on surveillance, molecular epidemiology, immunisation coverage, outbreak response and overall programme performance, then carried out a field visit in July before recommending approval. Dr Nilesh Buddha said: “Thailand has shown that rubella elimination is achievable when strong political commitment, resilient immunization services, high-quality surveillance and community trust come together.” WHO added that the verification means Thailand has interrupted endemic rubella virus transmission and has the systems needed to hold that ground.
Thai officials have presented the milestone as the public-health payoff from policies maintained across several governments. Thailand Plus and Hfocus, both citing the Ministry of Public Health, said WHO sent the Thai government a formal letter of congratulations on 25 August 2026 before posting the verification publicly on 5 September. Public Health Minister Pattana Promphat said the outcome reflected decades of work by health workers, volunteers, laboratories, provincial teams, schools, local authorities and parents who kept children coming forward for vaccination.
The ministry’s own press office cast the news not simply as a statistical win but as protection against permanent disability. In comments carried by the ministry and repeated by Thailand Plus, senior official Somruek Chungsaman said many Thais may now barely recognise rubella because vaccination has driven case numbers so low. He stressed that the disease once posed a serious threat, especially in early pregnancy, when infection can end in miscarriage, foetal death or congenital rubella syndrome. That syndrome can leave children with heart defects, hearing loss, sight problems and other lifelong impairments, which is why, he said, elimination is about preventing babies being born with avoidable disability rather than merely cutting reported infections.
Thailand’s immunisation programme began in 1977, years before rubella had receded from everyday concern. WHO says a rubella-containing vaccine entered the national schedule in 1986 for six-year-old girls in primary school and was widened in 1993 to all children aged one. Since then the health system has built up routine vaccination, outbreak response and laboratory-backed fever-and-rash surveillance, while also trying to reach underserved and mobile populations that can be missed by standard services. Thai reports said that long effort, rather than any short campaign, is what persuaded regional reviewers that the country’s evidence was robust.
Even so, Thai health authorities are not describing the job as finished. Hfocus reported that officials warned imported cases could still threaten the status if immunity slips, and the Department of Disease Control’s guidance helps explain why the margin for error is small. The department says roughly 20% to 50% of infections can pass without symptoms, that the virus can spread from about two to three days before a rash appears until seven days afterwards, and that babies born with congenital rubella may continue shedding virus in the throat and urine for as long as a year. In its public advice, the department also notes that adults without immunity can become more severely ill than children.
Regionally, Thailand now joins Bhutan, DPR Korea, Maldives, Nepal, Sri Lanka and Timor-Leste in rubella elimination, while Bhutan, DPR Korea, Maldives and Timor-Leste have gone further and secured verification for both measles and rubella. That wider race matters to WHO because each national success reduces the risk of congenital rubella syndrome across borders. Dr Ailan Li, WHO representative to Thailand, said the agency wanted to “accelerate progress towards measles elimination” with the ministry and its partners. Thailand’s next challenge, then, is not to celebrate a finish line, but to prove it can keep rubella out while crossing another one.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
